Methicillin-resistant Staphylococcus aureus: An update

AORN Journal

Volumn 91, Issue 5, 2010, Pages 599-609

  Durai, Rajaraman ^a   Ng, Philip C H ^a   Hoque, Happy ^b  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^b QUEEN MARY S HOSPITAL   (United Kingdom)

Author keywords

Antibiotic resistance; Community acquired infection; Health care associated infection; Infection; Methicillin resistant Staphylococcus aureus; MRSA

Indexed keywords

ANTIINFECTIVE AGENT; STAPHYLOCOCCUS VACCINE;

ARTICLE; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; HETEROZYGOTE; HUMAN; IMMUNOLOGY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGY; OPERATING ROOM PERSONNEL; PATHOGENICITY; RISK FACTOR; SKIN CARE; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OPERATING ROOM NURSING; RISK FACTORS; SKIN CARE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES;

EID: 77954837462     PISSN: 00012092     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aorn.2009.11.065     Document Type: Article

References (46)

1. Wang L., Barrett J.F. Control and prevention of MRSA infections. Methods Mol Biol 2007, 391:209-225.
2. Barada K., Hanaki H., Yamaguchi Y., et al. Trends of beta-lactam antibiotic susceptibility in blood-borne methicillin-resistant Staphylococcus aureus (MRSA) and their linkage to the staphylococcal cassette chromosome mec (SCCmec) type. J Infect Chemother 2007, 13(4):213-218.
3. Palavecino E. Clinical, epidemiological, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections. Methods Mol Biol 2007, 391:1-19.
4. Forestier E., Rémy V., Mohseni-Zadeh M., et al. MRSA Bacteremia: recent epidemiological and therapeutical trends. Rev Med Interne 2007, 28(11):746-755. [in French].
5. Tacconelli E., De Angelis G., Cataldo M.A., Pozzi E., Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation?. A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61(1):26-38.
6. Witte W., Mielke M. Community MRSA. Zentralbl Chir 2007, 132(2):124-129. [in German].
7. Morita J.E., Fujioka R.S., Tice A.D., et al. Survey of methicillin-resistant Staphylococcus aureus (MRSA) carriage in healthy college students, Hawai'i. Hawaii Med J 2007, 66(8):213-215.
8. Weese J.S., Dick H., Willey B.M., et al. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 2006, 115(1-3):148-155.
9. Shaw B.E., Boswell T., Byrne J.L., Yates C., Russell N.H. Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplant 2007, 39(10):623-629.
10. Oie S., Suenaga S., Sawa A., Kamiya A. Association between isolation sites of methicillin-resistant Staphylococcus aureus (MRSA) in patients with MRSA-positive body sites and MRSA contamination in their surrounding environmental surfaces. Jpn J Infect Dis 2007, 60(6):367-369.
11. Tadiparthi S., Shokrollahi K., Juma A., Croall J. Using marker pens on patients: a potential source of cross infection with MRSA. Ann R Coll Surg Engl 2007, 89(7):661-664.
12. Nguyen D.Q., Ramus N.I. A fatal case of MRSA septicaemia and gallbladder empyema. Int J Surg 2004, 2(2):120-121.
13. Albright J.B., Pidala M.J., Cali J.R., Snyder M.J., Voloyiannis T., Bailey H.R. MRSA-related perianal abscesses: an underrecognized disease entity. Dis Colon Rectum 2007, 50(7):996-1003.
14. Busch B.A., Ahern M.T., Topinka M., Jenkins J.J., Weiser M.A. Eschar with cellulitis as a clinical predictor in community-acquired MRSA skin abscess. J Emerg Med July 8, 2008, [Epub ahead of print].
15. Millar B.C., Prendergast B.D., Moore J.E. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 2007, 61(1):1-7.
16. Chan Y.C., Morales J., Burnand K.G. Development of simultaneous anastomotic false aneurysms at both ends of an autologous vein graft caused by methicillin-resistant Staphylococcus aureus (MRSA). Acta Chir Belg 2006, 106(5):619-621.
17. Moritani C., Taooka Y., Mito A., et al. Clinical study of 37 pneumonia patients in whom MRSA was identified from sputum. Nihon Kokyuki Gakkai Zasshi 2007, 45(2):146-152. [in Japanese].
18. Simon V. MRSA in otorhinolaryngology. Laryngorhinootologie 2007, 86(10):738-747. [in German].
19. Morimoto Y., Sugiura T., Tatebayashi S., Kirita T. Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer. Spec Care Dentist 2006, 26(5):209-213.
20. Burns C.A. Long-term use of daptomycin for MRSA osteomyelitis and joint infection. Scand J Infect Dis 2008, 40(2):183-186.
21. Livorsi D.J., Daver N.G., Atmar R.L., Shelburne S.A., White A.C., Musher D.M. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA. J Infect 2008, 57(2):128-131.
22. van Hal S.J., Stark D., Lockwood B., Marriott D., Harkness J. Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and Geno Type MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 2007, 45(8):2486-2490.
23. Zhang S.X., Drews S.J., Tomassi J., Katz K.C. Comparison of two versions of the IDI-MRSA assay using charcoal swabs for prospective nasal and nonnasal surveillance samples. J Clin Microbiol 2007, 45(7):2278-2280.
24. Batra R., Eziefula A.C., Wyncoll D., Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008, 34(9):1703-1706.
25. Gómez J., García-Vázquez E., Baños R., et al. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis 2007, 26(4):239-245.
26. Udo E.E., Al-Sweih N., Mokaddas E., et al. Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004. BMC Infect Dis 2006, 6:168.
27. Renders N.H., Janssen M.H., Leenders A.C. Clindamycin is unsuitable for the empirical treatment of infections due to pig-related methicillin-resistant Staphylococcus aureus (MRSA). Ned Tijdschr Geneeskd 2007, 151(41):2277-2280. [in Dutch].
28. Onlen Y., Duran N., Atik E., et al. Antibacterial activity of propolis against MRSA and synergism with topical mupirocin. J Altern Complement Med 2007, 13(7):713-718.
29. Maeda Y., Loughrey A., Earle J.A., et al. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Complement Ther Clin Pract 2008, 14(2):77-82.
30. Blaser G., Santos K., Bode U., Vetter H., Simon A. Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 2007, 16(8):325-328.
31. Rossney A., O'Connell S. Emerging high-level mupirocin resistance among MRSA isolates in Ireland. Euro Surveill 2008, 13(14). piii, 8084.
32. Bhattacharyya M., Bradley H. A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery. Int J Low Extrem Wounds 2008, 7(1):45-48.
33. Okano M., Noguchi S., Tabata K., Matsumoto Y. Topical gentian violet for cutaneous infection and nasal carriage with MRSA. Int J Dermatol 2000, 39(12):942-944.
34. Dryden M.S., Dailly S., Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 2004, 56(4):283-286.
35. Miedzybrodzki R., Fortuna W., Weber-Dabrowska B., Górski A. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. Postepy Hig Med Dosw (online) 2007, 61:461-465.
36. Mann N.H. The potential of phages to prevent MRSA infections. Res Microbiol 2008, 159(5):400-405.
37. Hansen D., Patzke P.I., Werfel U., Benner D., Brauksiepe A., Popp W. Success of MRSA eradication in hospital routine: depends on compliance. Infection 2007, 35(4):260-264.
38. Diller R., Sonntag A.K., Mellmann A., et al. Evidence for cost reduction based on pre-admission MRSA screening in general surgery. Int J Hyg Environ Health 2008, 211(1-2):205-212.
39. Gavaldà L., Masuet C., Beltran J., et al. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. Infect Control Hosp Epidemiol 2006, 27(11):1264-1266.
40. Hardy K.J., Gossain S., Henderson N., et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 2007, 66(4):360-368.
41. Xu X., Tang X.H., Xie G.E. Preparation, characterization and preliminary application of monoclonal antibody against the transpeptidase domain of MRSA-PBP2a. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007, 23(6):552-555. [in Chinese].
42. Maruyama T., Yamamoto Y., Kano Y., et al. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity. Bioorg Med Chem 2007, 15(19):6379-6387.
43. Buenz E.J., Bauer B.A., Schnepple D.J., Wahner-Roedler D.L., Vandell A.G., Howe C.L. A randomized Phase I study of Atuna racemosa: a potential new anti-MRSA natural product extract. J Ethnopharmacol 2007, 114(3):371-376.
44. Bubeck Wardenburg J., Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008, 205(2):287-294.
45. Roth D.M., Senna J.P., Machado D.C. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus. Genet Mol Res 2006, 5(3):503-512.
46. MRSA screening. Salisbury NHS Foundation Trust Accessed February 19, 2010. http://www.salisbury.nhs.uk/informationforpatients/patientleaflets/infectioncontrol/mrsascreeningpi.asp.